pamidronate has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zubair Ullah, HM | 1 |
| Surya, A | 1 |
| Morley, N | 1 |
| Ahmad, S | 1 |
| Jude, EB | 1 |
| Selby, PL | 1 |
| Burgess, J | 1 |
| Lilleystone, P | 1 |
| Mawer, EB | 1 |
| Page, SR | 1 |
| Donohoe, M | 1 |
| Foster, AV | 1 |
| Edmonds, ME | 1 |
| Boulton, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pamidronate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Biomarkers; Bo | 2001 |
1 other study available for pamidronate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Isolated splenic sarcoidosis: a rare cause of hypercalcaemia in a patient with type 1 diabetes.
Topics: Adult; Diabetes Mellitus, Type 1; Humans; Hypercalcemia; Male; Pamidronate; Sarcoidosis; Splenic Dis | 2021 |